PubMed=15274292
Qian Li, Claire F. Verschraegen, John T. Mendoza, Raffit Hassan;
Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38, towards tumor cell lines established from ascites of patients with peritoneal mesotheliomas.
Anticancer Res. 24:1327-1335(2004)

PubMed=22426987; DOI=10.3892/or.2012.1725; PMCID=PMC6310027
Neetu Kalra, Ali Ashai, Li-Qiang Xi, Jing-Li Zhang, Itzhak Avital, Mark Raffeld, Raffit Hassan;
Patients with peritoneal mesothelioma lack epidermal growth factor receptor tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors.
Oncol. Rep. 27:1794-1800(2012)

PubMed=22552293; DOI=10.1158/0008-5472.CAN-11-3481; PMCID=PMC3389268
Sandro Jube, Zeyana S. Rivera, Marco Emilio Bianchi, Amy Powers, Ena Wang, Ian Pagano, Harvey I. Pass, Giovanni Gaudino, Michele Carbone, Hai-Ning Yang;
Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma.
Cancer Res. 72:3290-3301(2012)

PubMed=22893632; DOI=10.1158/1078-0432.CCR-12-0628; PMCID=PMC3463742
Zeyana S. Rivera, Soldano Ferrone, Xin-Hui Wang, Sandro Jube, Hai-Ning Yang, Harvey I. Pass, Shreya Kanodia, Giovanni Gaudino, Michele Carbone;
CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma.
Clin. Cancer Res. 18:5352-5363(2012)